Biaxin and Ejection fraction - a phase IV clinical study of FDA data

Summary:

Ejection fraction is reported as a side effect among people who take Biaxin (clarithromycin), especially for people who are male, 20-29 old, also take Flovent,.

The phase IV clinical study analyzes which people have Ejection fraction when taking Biaxin. It is created by eHealthMe based on reports of 13,608 people who have side effects when taking Biaxin from the FDA, and is updated regularly.

What is Biaxin?

Biaxin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 14,248 Biaxin users. Check the latest studies of Biaxin.

What is Ejection fraction?

Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat) is found to be associated with 375 drugs and 324 conditions by eHealthMe. Check the latest studies of Ejection fraction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

13,608 people reported to have side effects when taking Biaxin.
Among them, 21 people (0.15%) have Ejection fraction.

$Could Biaxin cause Ejection fraction?$

Among these 21 people:

What is the gender of people who have Ejection fraction when taking Biaxin? *

female: 9.52 %
male: 90.48 %

What is the age of people who have Ejection fraction when taking Biaxin? *

What are other drugs people take besides Biaxin? *

What are other side effects people have besides Ejection fraction? *

Cardiac Failure Congestive: 9 people, 42.86%
Churg Strauss Syndrome (infection of small arteries and vein): 7 people, 33.33%
Chest Pain: 7 people, 33.33%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 28.57%
Back Pain: 6 people, 28.57%
Hypotension (abnormally low blood pressure): 6 people, 28.57%
Mitral Valve Incompetence (inefficient heart valve): 6 people, 28.57%
Weakness: 6 people, 28.57%
Nausea (feeling of having an urge to vomit): 5 people, 23.81%
Muscle Aches (muscle pain): 5 people, 23.81%

* Approximation only. Some reports may have incomplete information.

Do you take Biaxin and have Ejection fraction?

- Check whether Ejection fraction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biaxin:

Biaxin (14,248 reports)

Browse all side effects of Biaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ejection fraction:

Ejection fraction (375 drugs)

Browse all the conditions that are associated with Ejection fraction:

Ejection fraction (324 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin (the active ingredients of Biaxin) and Biaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.